Search filters

List of works by Francis W Hunter

Dual targeting of hypoxia and homologous recombination repair dysfunction in triple-negative breast cancer.

scientific article published on 5 September 2014

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

scientific article published on 23 August 2018

Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of Evofosfamide

scientific article published on 12 April 2019

Homologous recombination repair-dependent cytotoxicity of the benzotriazine di-N-oxide CEN-209: comparison with other hypoxia-activated prodrugs.

scientific article published on 13 December 2011

Hypoxia-activated prodrugs: paths forward in the era of personalised medicine.

scientific article published on 12 April 2016

Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361

scientific article published on 18 September 2019

Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs.

scientific article published on 21 August 2015

Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer

scientific article published on 16 December 2019

Old target; new paradigm: Determinants of sensitivity to hypoxia-directed anticancer prodrugs ⬇️

2014 doctoral thesis by Francis Hunter at University of Auckland

Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia

scientific article published on 17 September 2019

The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs

scientific article published on 13 March 2014

Paulina is supported by:

About Paulina

Help